Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why [Yahoo! Finance]
Structure Therapeutics Inc. - American Depositary Shares (GPCR)
Company Research
Source: Yahoo! Finance
the past three months, with a major surge since early December after reporting positive data related to its oral obesity pill. Stock market data showing an upward trajectory. Photo by Burak The Weekender on Pexels A study testing aleniglipron on obese or overweight patients, with one or more co-morbidities tied to weight, demonstrated a weight loss of 11.3% after being treated for 36 weeks at a dosage of 120 mg. This was a significant development, given that most of the market is concentrated in injectables. Structure Therapeutics Inc. (NASDAQ:GPCR) also shared that there is another clinical research ongoing, testing participants with a 240 mg dose, which produced even better results, with a weight loss of 15.3% at 36 weeks. In other news, on December 17, the company announced that it was beginning the first human-based trial of ACCG-2671, an oral small-molecule amylin receptor to treat obesity. Wall Street analysts have a bullish outlook for the stock, with a consensus Stro
Show less
Read more
Impact Snapshot
Event Time:
GPCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GPCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GPCR alerts
High impacting Structure Therapeutics Inc. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GPCR
News
- Can This Stock Double Again in 2026? [Yahoo! Finance]Yahoo! Finance
- H.C. Wainwright Upgrades Structure Therapeutics (GPCR) on Massive Arbitrage Opportunity for Oral GLP-1 [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics (NASDAQ:GPCR) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.MarketBeat
- Structure Therapeutics (GPCR) valuation check after Phase 1 obesity candidate ACCG-2671 enters first-in-human trial [Yahoo! Finance]Yahoo! Finance
- Structure Therapeutics (NASDAQ:GPCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
GPCR
Sec Filings
- 1/5/26 - Form 8-K
- 12/10/25 - Form 8-K
- 12/10/25 - Form 424B5
- GPCR's page on the SEC website